SBS is a rare condition in which patients are ... to progress into phase 3 development," said 9 Meters' chief medical officer Patrick Griffin. "Vurolenatide may offer a novel and alternative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback